1. Home
  2. PGEN vs CXM Comparison

PGEN vs CXM Comparison

Compare PGEN & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$3.81

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Sprinklr Inc.

CXM

Sprinklr Inc.

HOLD

Current Price

$5.35

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
CXM
Founded
1998
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
PGEN
CXM
Price
$3.81
$5.35
Analyst Decision
Buy
Hold
Analyst Count
5
8
Target Price
$8.33
$8.28
AVG Volume (30 Days)
4.0M
3.1M
Earning Date
05-13-2026
06-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
$230,981,000.00
$857,200,000.00
Revenue This Year
$1,115.92
$2.52
Revenue Next Year
$81.04
$4.94
P/E Ratio
N/A
$62.44
Revenue Growth
N/A
7.64
52 Week Low
$1.30
$4.72
52 Week High
$5.47
$9.40

Technical Indicators

Market Signals
Indicator
PGEN
CXM
Relative Strength Index (RSI) 38.10 50.08
Support Level $3.49 $5.19
Resistance Level $4.40 $5.60
Average True Range (ATR) 0.29 0.25
MACD -0.07 0.06
Stochastic Oscillator 2.97 45.76

Price Performance

Historical Comparison
PGEN
CXM

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale, all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights, and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: